SEARCH

SEARCH BY CITATION

References

  • 1
    Riikonen R. Infantile spasms in siblings. J Pediatr Neurosci 1987;3:23544.
  • 2
    Salonen R, Somer M, Haltia M, Lorentz M, Norio R. Progressive encephalopathy with edema, hypsarrhythmia, and optic atrophy (PEHO syndrome). Clin Genet 1991;39:28793.
  • 3
    Somer M. Diagnostic criteria and genetics of the PEHO syndrome. J Med Genet 1993;30:9326.
  • 4
    Somer M, Sainio K. Epilepsy and the electroencephalogram in progressive encephalopathy with edema, hypsarrhythmia, and optic atrophy (the PEHO syndrome. Epilepsia 1993;34:72731.
  • 5
    Somer M, Salonen O, Pihko H, Norio R. PEHO syndrome (progressive encephalopathy with edema, hypsarrhythmia, and optic atrophy): neuroradiologic findings. AJNR Am J Neuroradiol 1993;14:8617.
  • 6
    Somer M, Setälä K, Kivelä T, Haltia M, Norio R. The PEHO syndrome (progressive encephalopathy with oedema, hypsarrhythmia and optic atrophy). Neuroophthalmology 1993;13:6574.
  • 7
    Haltia M, Somer M. Infantile cerebello-optic atrophy; neuropathology of the progressive encephalopathy syndrome with edema, hypsarrhythmia, and optic atrophy (the PEHO syndrome). Acta Neuropathol 1993;85:2417.
  • 8
    Fujimoto S, Yokochi K, Nakano M, Wada Y. Progressive encephalopathy with edema, hypsarrhythmia, and optic atrophy (PEHO syndrome) in two Japanese siblings. Neuropediatrics 1995;26:2702.
  • 9
    Chitty L., Robb S, Berry C, Silver D, Baraitser M. PEHO or PEHO-like syndrome. Clin Dysmorph 1996;5:14352.
  • 10
    Shevell MI, Colangelo P, Treacy E, Polomeno RC, Rosenblatt B. Progressive encephalopathy with edema, hypsarrhythmia, and optic atrophy (PEHO syndrome). Pediatr Neurol 1996;15:3379.
  • 11
    Harvey AS, Jayakar P, Duchowny M, et al. Hemifacial seizures and cerebellar ganglioglioma: an epilepsy syndrome of infants with seizures of cerebellar origin. Ann Neurol 1996;40:918.
  • 12
    McLone DG, Stieg PE, Scott RM, Barnett F, Barnes PD, Folkerth R. Cerebellar epilepsy. Neurosurgery 1998;42:110611.
  • 13
    Baker J, Liu J-P, Robertson E, Efstratiadis A. Role of insulin-like growth factors in embryonic and postnatal growth. Cell 1993;75:7382.
  • 14
    Liu J-P, Baker J, Perkins A, Robertson E, Efstratiadis A. Mice carrying null mutations of genes encoding insulin-like growth factor I (IGF-1) and type I IGF-receptor (IGF-R. Cell 1993;75:5972.
  • 15
    Jones J, Clemmons D. Insulin-like growth factors and their binding protein: biological actions. Endocr Rev 1995;16:334.
  • 16
    Höppener J, de Pagter- Holthuizen P, Geurts van Kessel A, et al. The human gene encoding insulin-like growth factor I is located on chromosom. 12. Hum Genet 1985;69:15760.
  • 17
    Rechler M, Nissley S. Insulin-like growth factors: In: SpornM, RobertsA, eds. Handbook of experimental pharmacology: peptide growth factors and their receptors. I. Berlin : Springer-Verlag. 1989; 263367.
  • 18
    Beck K, Bowell-Braxton L, Wildmer H, Valverde J, Hefti F. IGF-1 gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal granule and striatal paralbumin-containing neurons. Neuron 1995;14:1730.
  • 19
    Vig P, Desaiaah D, Joshi P, Subramony S, Fratkin J, Currier R. Decreased insulin-like growth factor-I-mediated protein tyrosine phosphorylation in human olivopontocerebellar atrophy and lurcher mutant mouse. J Neurol Sci 1991;124:3844.
  • 20
    Komoly S, Hudson L, Webster H, et al. Insulin-like growth factor I gene expression is induced in astrocytes during experimental demyelination. Pro. Natl Acad Sci U S A 1992;89:18948.
  • 21
    Guthrie K, Nguen T, Gall C. Insulin-like growth factor-1 MRNA is increased in deafferented hippocampus: spatio-temporal correspondence of a trophic event with axon sprouting. J Comp Neurol 1995;352:14760.
  • 22
    D'Mello S, Galli C, Ciotti T, Calissano P. Induction of apoptosis in cerebellar granule neurons by potassium. Proc Natl Acad Sci U S A 1993;90:1098993.
  • 23
    Torres-Aleman I, Poins S, Santos-Benito F. Survival of Purkinje cells in cerebellar cultures is increased by insulin-like growth factor 1. Eur J Neurosci 1992;4:8649.
  • 24
    Torres-Aleman I, Villaba M, Nieto-Bona M. Insulin-like growth factor-1 modulation of cerebellar cell populations is developmen-tally stage-dependent and mediated by specific intracellular pathways. Neuroscience 1998;83:32134.
  • 25
    Torres-Aleman I, Barrios V, Lledo A, Berciano J. The insulin-like growth factor I system in cerebellar degeneration. Ann Neurol 1996;39:33542.
  • 26
    Sorva R, Tolppanen EM, Lankinen S, Perheentupa J. Growth evaluation: parent and specific height standards. Arch Dis Child 1989;64:14837.
  • 27
    Mincler J. Pathology of the nervous system. Vol 1. New York : McGraw-Hill, 1968: 123.
  • 28
    Nikali K, Isosomppi T, Lönnqvist T, Mao J, Suomalainen A, Peltonen L. Toward cloning of a novel ataxia gene: refined assigment and physical map of the IOSCA locus (SCA8) on 10q24. Genomics 1997;39:18591.
  • 29
    Blum P. Insulin-like growth factor-binding protein 3: Entwicking eines radioimmunoassays und untersuchungen zur klinischen be-deutung. Tubingen: Der Medizinischen Fakultät der Universität Tübingen, Habilitationsschrift, 1993: 11921.
  • 30
    Harding A. Clinical features and classification of inherited ataxias. In: HardingAE, DeufelT, eds. Inherited ataxias. New York : Raven Press. 1993: 114.
  • 31
    Jellinger K. Neuropathological aspects of infantile spasms. Brain Dev 1987;9:34957.
  • 32
    Hintz R, Liu F, Seegan G. Characterization of an insulin-like growth factor-I/somatomedin C radioimmunoassay specific for the C-peptide region. J Clin Endocrinol Metab 1982;55:92730.
  • 33
    Zapf J, Morell B, Walter H, et al. Serum levels of insulin-like growth factor (IGF) and its carrier protein in various metabolic disorders. Acta Endocrinol (Copenh) 1980;95:50517.
  • 34
    Isley W., Underwood L., Clemmons D. Dietary components that regulate serum somatomedin-C concentrations in humans. J Clin Invest 1983;71:17582.
  • 35
    Tham A, Nordberg A, Grisson E, Carlsson-Skwirut C, Viitanen M, Sara V. Insulin-like growth factor binding proteins in cerebrospinal fluid and serum in patients with dementia of the Alzheimer type. J Neural Transm 1993;5:16576.
  • 36
    Bondy C, Werner H, Roberts C, et al. Cellular pattern of type-I insulin-like growth factor receptor gene expression during maturation of the rat brain: comparison with insulin-like growth factors I and II. Neuroscience 1992;46:90923.
  • 37
    Bach M, Shen-Orr Z, Lowe W, Roberts C, LeRoith D. Insulin-like growth factor I mRNA levels are developmentally regulated in specific regions of the rat brain. Mol Brain Res 1991;10:438.
  • 38
    Werther G, Russo V, Baker N, Butler G. The role of the insulin-like growth factor system in the developing brain. Horm Res 1998;49:3740.
  • 39
    Dudek H, Datta S, Franke T, et al. Regulation of neuronal survival by serine-threonine protein kinase. Akt Sci 1997;275:6615.
  • 40
    Gao W, Heintz N, Hatten M. Cerebellar granule cell neurogenesis is regulated by cell-cell interactions in vitro. Neuron 1991;6:70515.
  • 41
    Barres BA. Cell death and control of cell survival in the oligoden-drocyte lineage. Cell 1992;70:3146.
  • 42
    Bondy C. Transient IGF-1 gene expression during the maturation of functionally related central projection neurons. J Neurosci 1991;11:344255.
  • 43
    Reinhardt RR, Bondy CA. Insulin-like growth factors cross the blood-brain barrier. Endocrinology 1994;135:175361.
  • 44
    Fernandez A, de la Vega A, Torres-Aleman I. Insulin-like growth factor. Proc Natl Sci U S A 1998;95:12538.